Dairy giant Fonterra is denying claims it has covered up
possible health risks from drinking milk.
The claims are part of a high court case being brought
by a rival.
A2 Milk Corporation is producing a new type of milk,
one without the protein, linked by research, to heart disease, diabetes
and mental disorders.
Milk is a symbol of goodness but a high court document
claims that the public has not been told the whole truth.
It cites a dairy board briefing paper two years ago
which states: "If the media were ever able to assemble the information
shown in this paper they could put an alarmist spin on the whole area of
milk consumption."
"We think the Dairy Board has had information that
they should have acted upon and didn't" Jim Guthrie Chairman of A2 Milk
Corporation says.
Guthrie, the chairman of the company that is producing
a new kind of milk, says that A2 does not have the protein present in
normal A1 milk which some research has linked to heart disease, diabetes
and mental disorders.
The dairy board admits in the briefing paper: "...The
contents of this briefing paper could form the basis for an argument for
the production of A2 milk for at risk individuals."
But Fonterra says that paper is well out of date.
As far as we are concerned there is no evidence at all
linking the drinking of milk with any of the health disorders that A2
allege," Chris Mallet of Fonterra says.
A2 wants the high court to order Fonterra to place a
health warning on all the milk the public buy but the legal battle may
well be more about marketing than anything else - A2 expects to have its
milk on supermarket shelves by the end of the year.
Most New Zealand cows produce A1 milk, but thousands
of cows are now being selected to produce A2.
Fonterra says A2's claims should not put people off
normal milk.
"We think its irresponsible because it neglects the
very substantial health benefits it brings to people who consume it,"
Mallet says.
Fonterra says it will fight hard in court to protect
its key product.
Source:
ONE News sourced from TVNZ, RNZ, Reuters and AAP.